tiprankstipranks
Elevation Oncology (ELEV)
NASDAQ:ELEV
US Market

Elevation Oncology (ELEV) Technical Analysis

215 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Elevation Oncology’s (ELEV) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting Elevation Oncology is a Sell.
Elevation Oncology’s (ELEV) 20-Day exponential moving average is 2.84, while Elevation Oncology’s (ELEV) share price is $2.64, making it a Sell.
Elevation Oncology’s (ELEV) 50-Day exponential moving average is 3.13, while Elevation Oncology’s (ELEV) share price is $2.64, making it a Sell.

Elevation Oncology (ELEV) Pivot Points

Jul 22, 2024, 01:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.30
2.47
2.57
2.73
2.83
3.00
3.10
Fibonacci
2.47
2.57
2.63
2.73
2.83
2.90
3.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Elevation Oncology (ELEV) Moving Averages

Jul 22, 2024, 01:26 PM
Period
Simple
Exponential
MA5
2.84Sell
2.76Sell
MA10
2.79Sell
2.78Sell
MA20
2.70Sell
2.84Sell
MA50
3.22Sell
3.13Sell
MA100
3.79Sell
3.19Sell
MA200
2.53Buy
2.42Buy
Elevation Oncology’s (ELEV) 10-Day exponential moving average is 2.78, while Elevation Oncology’s (ELEV) share price is $2.64, making it a Sell.
Elevation Oncology’s (ELEV) 100-Day exponential moving average is 3.19, while Elevation Oncology’s (ELEV) share price is $2.64, making it a Sell.
Elevation Oncology’s (ELEV) stock price is $2.64 and Elevation Oncology’s (ELEV) 50-day simple moving average is 3.22, creating a Sell signal.
Elevation Oncology’s (ELEV) stock price is $2.64 and Elevation Oncology’s (ELEV) 100-day simple moving average is 3.79, creating a Sell signal.
Elevation Oncology’s (ELEV) stock price is $2.64 and Elevation Oncology’s (ELEV) 200-day simple moving average is 2.53, creating a Buy signal.

Elevation Oncology (ELEV) Technical Indicators

Jul 22, 2024, 01:26 PM
Name
Value
Implied Action
RSI (14)
40.33
Neutral
STOCH (9,6)
26.13
Neutral
STOCHRSI (14)
32.52
Neutral
MACD (12,26)
-0.12
Sell
ADX (14)
20.02
Neutral
Williams %R
-86.49
Buy
CCI (14)
-15.93
Neutral
ATR (14)
0.25
-
Ultimate Oscillator
41.55
Neutral
ROC
-2.22
Sell
Elevation Oncology’s (ELEV) Relative Strength Index (RSI) is 40.33, creating a Neutral signal.
Elevation Oncology’s (ELEV) Trend Strength Indicator (ADX) is 20.02, creating a Neutral signal.
Elevation Oncology’s (ELEV) Commodity Channel Index (CCI) is -15.93, creating a Neutral signal.
Elevation Oncology’s (ELEV) Price Rate of Change (ROC) is -2.22, creating a Sell signal.

FAQ

Is ELEV a Buy, Hold, or Sell?
Based on ELEV’s technical indicators, ELEV is a Sell.
    What is ELEV’s RSI (14)?
    ELEV’s RSI (14) is 40.33, which suggests ELEV is a Neutral.
      What is ELEV’s MACD?
      ELEV’s MACD is -0.12, which suggests ELEV is a Sell.
        What is ELEV’s 5-day moving average?
        ELEV’s 5-day moving average is 2.84, which suggests ELEV is a Sell.
          What is ELEV’s 20-day moving average?
          ELEV 20-day moving average is 2.70, which suggests ELEV is a Sell.
            What is ELEV’s 50-day moving average?
            ELEV’s 50-day moving average is 3.22, which suggests ELEV is a Sell.
              What is ELEV’s 200-day moving average?
              ELEV’s 200-day moving average is 2.53, which suggests ELEV is a Buy.
                What is ELEV’s Williams % R (14)?
                ELEV’s Williams % R (14) is -86.49, which suggests ELEV is a Buy.
                  What is ELEV’s CCI (14)?
                  ELEV’s CCI (14) is -15.93, which suggests ELEV is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis